BACKGROUND: Sugar absorption tests are an effective, noninvasive way to assess intestinal permeability. The role of intestinal barrier integrity in complications and outcome of short-bowel syndrome is not known. The purpose of the study was to evaluate whether such tests provide information on the status of intestinal mucosa of these patients. METHODS: Six children with short-bowel syndrome--median age, 12 months, and median small bowel length at birth, 30 cm--had a sugar test with 3-o-methyl-D-glucose, D-xylose, D-rhamnose, and melibiose approximately 2 months after operation. The melibiose/L-rhamnose ratio was used as an index of permeability, and percentages of 3-o-methyl-D-glucose and D-xylose absorbed were used as indices of absorption. Parenteral nutrition requirement, bowel length, liver disease, recent sepsis, and bacterial overgrowth were recorded. RESULTS: Three patients had increased permeability, and all of them had had a recent episode of sepsis and severe liver disease. All subjects had malabsorption of 3-o-methyl-D-glucose, and five of six had malabsorption of D-xylose and L-rhamnose. The absorption of 3-o-methyl-D-glucose correlated with bowel length (r2 = 0.78; P = 0.04), whereas the absorption of D-xylose correlated with parenteral requirement (r2 = 0.66; P = 0.04) at that time. CONCLUSIONS: Increased permeability was observed in three of six patients with short-bowel syndrome associated with a recent episode of sepsis and severe liver disease. Other indices of malabsorption correlated significantly with different clinical features of the disease. A prospective larger scale study in a homogeneous population is indicated to assess at multiple points during the disease course whether the test can be helpful in the management of these patients.
BACKGROUND:Sugar absorption tests are an effective, noninvasive way to assess intestinal permeability. The role of intestinal barrier integrity in complications and outcome of short-bowel syndrome is not known. The purpose of the study was to evaluate whether such tests provide information on the status of intestinal mucosa of these patients. METHODS: Six children with short-bowel syndrome--median age, 12 months, and median small bowel length at birth, 30 cm--had a sugar test with 3-o-methyl-D-glucose, D-xylose, D-rhamnose, and melibiose approximately 2 months after operation. The melibiose/L-rhamnose ratio was used as an index of permeability, and percentages of 3-o-methyl-D-glucose and D-xylose absorbed were used as indices of absorption. Parenteral nutrition requirement, bowel length, liver disease, recent sepsis, and bacterial overgrowth were recorded. RESULTS: Three patients had increased permeability, and all of them had had a recent episode of sepsis and severe liver disease. All subjects had malabsorption of 3-o-methyl-D-glucose, and five of six had malabsorption of D-xylose and L-rhamnose. The absorption of 3-o-methyl-D-glucose correlated with bowel length (r2 = 0.78; P = 0.04), whereas the absorption of D-xylose correlated with parenteral requirement (r2 = 0.66; P = 0.04) at that time. CONCLUSIONS: Increased permeability was observed in three of six patients with short-bowel syndrome associated with a recent episode of sepsis and severe liver disease. Other indices of malabsorption correlated significantly with different clinical features of the disease. A prospective larger scale study in a homogeneous population is indicated to assess at multiple points during the disease course whether the test can be helpful in the management of these patients.
Authors: Conrad R Cole; Juliana C Frem; Brian Schmotzer; Andrew T Gewirtz; Jonathan B Meddings; Benjamin D Gold; Thomas R Ziegler Journal: J Pediatr Date: 2010-02-20 Impact factor: 4.406
Authors: Matthew W Ralls; Farokh R Demehri; Yongjia Feng; Sasha Raskind; Chunhai Ruan; Arno Schintlmeister; Alexander Loy; Buck Hanson; David Berry; Charles F Burant; Daniel H Teitelbaum Journal: Am J Physiol Gastrointest Liver Physiol Date: 2016-09-01 Impact factor: 4.052
Authors: Ville Petteri Heljo; Antti Nordberg; Mikko Tenho; Tommi Virtanen; Kirsi Jouppila; Jarno Salonen; Sirkka Liisa Maunu; Anne Mari Juppo Journal: Pharm Res Date: 2011-12-28 Impact factor: 4.200
Authors: Ivan M Gutierrez; Kuang Horng Kang; Catherine E Calvert; Victor M Johnson; David Zurakowski; Daniel Kamin; Tom Jaksic; Christopher Duggan Journal: J Pediatr Surg Date: 2012-06 Impact factor: 2.545
Authors: Melissa A Hull; Brian A Jones; David Zurakowski; Bram Raphael; Clifford Lo; Tom Jaksic; Christopher Duggan Journal: JPEN J Parenter Enteral Nutr Date: 2011-03 Impact factor: 4.016
Authors: Matthew W Ralls; Farokh R Demehri; Yongjia Feng; Kathleen M Woods Ignatoski; Daniel H Teitelbaum Journal: Surgery Date: 2015-02-20 Impact factor: 3.982
Authors: Thomas R Ziegler; Menghua Luo; Concepción F Estívariz; Daniel A Moore; Shanthi V Sitaraman; Li Hao; Niloofar Bazargan; Jan-Michael Klapproth; Junqiang Tian; John R Galloway; Lorraine M Leader; Dean P Jones; Andrew T Gewirtz Journal: Am J Physiol Regul Integr Comp Physiol Date: 2007-11-14 Impact factor: 3.619
Authors: Danielle A Stamm; Elizabeth Hait; Heather J Litman; Paul D Mitchell; Christopher Duggan Journal: J Pediatr Gastroenterol Nutr Date: 2016-09 Impact factor: 2.839